This site is intended for health professionals only

Published on 9 July 2007

Share this story:

RELATED ARTICLES
Join us for new Clinical Excellence in Respiratory Care event
Dismayed reactions from sector over proposed GPhC fees increase
Dapagliflozin use in heart failure extended by NICE to reduce hospitalisations
Study confirms spironolactone safe and effective for treating acne in women
Calls for HCPs to respond to major conditions strategy consultation

AstraZeneca enters RNA interference field

teaser

AstraZeneca has signed a deal with the UK’s Silence Therapeutics that is worth up to



Most read

1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
2
Oral vitamin A could become an alternative to isotretinoin for acne
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
A new generation of drugs for schizophrenia
RPS launches consultations on critical care and mental health curricula for advanced pharmacist practice
Anti-smoking drug “kills”
GSK unveils plans for neurology drugs
COVID Delta variant viral load similar in vaccinated and unvaccinated

Download Hospital Pharmacy Europe free app

Download our app from the Apple App Store Download our app from Google Play

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x